The Field This Week

A new Medicaid work requirement could put coverage at risk for autistic adults and caregivers

CMS issued an interim final rule (CMS-2454-IFC) requiring non-pregnant Medicaid adults aged 19–64 in the expansion/adult group to demonstrate 80 hours per month of work, qualifying activity, or half-time education to keep eligibility. People who are disabled or medically frail are exempt — but CMS reads the exemption narrowly, requiring that the condition "significantly impairs" the ability to comply, not just that it exists.

The U.S. Department of Education is moving special-education oversight to HHS and civil-rights enforcement to DOJ

Through four interagency agreements, the Office of Special Education Programs and Rehabilitation Services Administration moves to HHS's Administration on Disabilities, while the Office for Civil Rights, student-privacy enforcement, and four equity-assistance centers move to the DOJ Civil Rights Division. Statutory responsibility for IDEA technically stays with Education; no effective date was specified.

North Carolina's draft Medicaid policy would sharply tighten ABA coverage

NC Medicaid's draft Clinical Coverage Policy 8F would bar telehealth for behavioral assessments and individual/group ABA, restrict out-of-state providers to within 40 miles of the border, require behavior technicians to hold national certification, and — in a December phase — bar providers from diagnosing autism and self-referring to their own ABA services.

Three states are suing the Education Department over canceled special-education grants

California, Rhode Island, and Wisconsin filed suit (N.D. Cal.) over the cancellation of State Personnel Development Grants under IDEA Part D — five-year awards halted around September 2025, allegedly over diversity/equity references — arguing the cancellations violated the Administrative Procedure Act.

Investigation: unproven stem-cell infusions are being marketed to families of autistic children

A Guardian investigation found clinics infusing autistic children — some as young as 18 months, sedated with ketamine — with umbilical-cord stem cells at costs up to roughly $20,000. These treatments are not FDA-approved and have no proven benefit; the largest controlled trial to date (Duke, 180 children) found no significant benefit for most participants.

A federal panel's push to fund "assisted spelling" draws objections from professional bodies

A federal autism panel passed a resolution urging HHS to support training in assisted spelling / facilitated communication. Autism-science organizations, psychologists, and speech-language pathologists oppose these methods, citing evidence that the facilitator — not the autistic person — may control the output.

Brain imaging points to two biologically distinct autism subtypes

Combining fMRI from 940 autistic and 1,036 neurotypical people with 20 genetic mouse models, an IIT (Italy) and Child Mind Institute team identified two cross-species connectivity patterns — a "hyperconnectivity" form tied to transcriptional/immune pathways and a "hypoconnectivity" form tied to synaptic dysfunction — together accounting for about a quarter of the studied population.

A new method separates inherited, parental, and environmental contributions to autism risk

Johns Hopkins and Kaiser Permanente researchers built PGS-TRI and applied it to 18,383 multi-ancestry parent-child trios from the SPARK cohort, separating a child's inherited genetic effects from indirect parental effects and gene–environment interactions.

Telehealth, parent-delivered early intervention shows early promise for infants

An Italian feasibility study of a telehealth-delivered Naturalistic Developmental Behavioral Intervention for infants showing early autism signs reported low attrition (6.7%), high parent satisfaction, and gains in caregiver strategy use alongside improvements in children's developmental and adaptive functioning.

Two new peer-reviewed papers on AI in autism — and a clear ethics warning

A systematic review across AI for autism detection, behavior analysis, and education concluded the field needs stronger transparency and ethical safeguards before broad real-world use. A separate facial-image model reported ~96% accuracy, but the authors themselves cautioned that their single dataset lacked demographic metadata and clinical confirmation.

Three coming BACB changes to plan around

• CE format change (effective July 1, 2026): article-plus-quiz and "code word" formats are no longer eligible; asynchronous CE must be interactive.
• RBT moves to 12 PDUs on a 2-year recertification cycle (effective January 1, 2026); the first PDU-based recertification deadline is January 2028.
• ACE Provider standards revised (effective July 1, 2026): tightened instructor qualifications; organizational providers must be legal entities.

Consolidation, closures, and credentialing: the field is being reshaped — here's the clinical read

Three forces are remaking who delivers ABA — and who gets served:

• Private equity is buying at pace. January 2026 alone saw General Atlantic-backed ACES acquire Ally Pediatric Therapy (now 92 locations) and Renovus-backed Behavioral Framework acquire Autism ETC. A JAMA Pediatrics study counts 574 autism service sites bought by private equity across 42 states since 2015. The catch families should watch: after buying Ally, ACES moved to end its in-house speech, OT, and feeding services — narrowing multidisciplinary care to ABA-only.
• Where deals stop, closures start. Medicaid rate cuts and rule changes are shuttering clinics — Autism Learning Partners (NY), Piece by Piece (IN), Easterseals Port Health (NC) — and driving layoffs (Arizona Autism, roughly 3,000). Families are losing access faster than the market replaces it.
• The credentialing ground shifted. ABAI and the BACB ended the Verified Course Sequence system on January 1, 2026 (BCBA Pathway 2 now uses Coursework Attestation), and the new RBT standards — including the 12-PDU, two-year recertification cycle — are now in effect.

Read the full analysis: ABA Industry Watch 2026 →

ForwardAustralia funds autistic-led initiatives under its National Autism Strategy

The Australian Government funded three autistic-led Reframing Autism initiatives: trauma-informed assessment resources, an "Autism In-Justice" youth-justice access program, and a peer-support partnership — putting autistic leadership at the center ("nothing about us without us").

FundingU.S. Education Dept. releases $144M more for special education and early intervention

The release included roughly $123.6M for IDEA Part B (ages 3–21) and $20.5M for Part C (birth–2), plus new guidance allowing states to extend Part C early-intervention support to expectant parents of children with disabilities.

The number to keep handy: autism prevalence is 1 in 31 children

The CDC's most recent estimate is 1 in 31 children. (The older 1-in-36 figure is from the prior 2020 cycle.) A calm, current number for any newly-diagnosed family trying to make sense of what they're reading.

These are real and important, but we can't yet pin them to a single settled fact or dated primary source, so we're flagging them as developing rather than reporting them as conclusions.

• Developing An HHS effort to assemble identifiable patient medical records for autism research, including to probe a long-discredited vaccine link, is drawing privacy and consent objections; some state health-information exchanges have declined.
• Developing Several states (NE, IN, NC, CO) are cutting or capping Medicaid ABA reimbursement amid steep spending growth — a national trend with per-state details still varying.
• Developing Provisions of the 2025 Medicaid law (H.R.1) begin phasing in, with advocates warning optional home- and community-based services may be cut first.
• Developing Early research links specific infant gut bacteria to lower likelihood of autism/ADHD signs — but causality is not established; treat as a hypothesis, not advice.